Zobraziť v EDS

Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators: impact of COVID-19 related shutdown on short-term key performance indicators

Uložené v:
Podrobná bibliografia
Názov: Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators: impact of COVID-19 related shutdown on short-term key performance indicators
Autori: Jidkova, S., Hoeck, S., Kellen, E., Cessie, S. le, Goossens, M.C.
Prispievatelia: Brussels Photonics, Supporting clinical sciences, FORMER_Laboratory for Medical and Molecular Oncology, Medical Oncology
Zdroj: BMC Cancer
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
BMC cancer
Informácie o vydavateľovi: Springer Science and Business Media LLC, 2022.
Rok vydania: 2022
Predmety: Adult, Male, 4202 Epidemiology, Patient Participation/statistics & numerical data, COLORECTAL-CANCER, 1117 Public Health and Health Services, Cancer screening, 03 medical and health sciences, 0302 clinical medicine, Belgium, 3211 Oncology and carcinogenesis, Neoplasms, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Breast, Belgium/epidemiology, Colorectal, RC254-282, Early Detection of Cancer, COVID-19/epidemiology, Delivery of Health Care/statistics & numerical data, Aged, Science & Technology, SARS-CoV-2, Research, Participation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, COVID-19, Interruption of screening, Middle Aged, Early Detection of Cancer/statistics & numerical data, 3. Good health, Oncology, Cervical, Female, Human medicine, Patient Participation, Life Sciences & Biomedicine, Delivery of Health Care, Neoplasms/diagnosis
Popis: Background Many breast, colorectal, and cervical cancer screening programs were disrupted due to the COVID-19 pandemic. This study aimed to estimate the short-term impact of the temporary shutdown (from March until May- June) of the cancer screening programs invitations in Flanders (Belgium) by looking at invitation coverage, percentage of people screened after invitation and the screening interval. Methods Yearly invitation coverage was calculated as the number of people who received an invitation, as a proportion of the people who should have received an invitation that year. Weekly response to the invitation was calculated as the number of people who were screened within 40 days of their date of invitation, as a percentage of the people who received an invitation that week (as a proxy for willingness to screen). Weekly screening interval was calculated as the mean number of months between the current screening and the previous screening of all the people who screened that week. The two last indicators were calculated for each week in 2019 and 2020, after which the difference between that week’s value in 2020 and 2019 with 95% confidence intervals. Results of these two indicators were also analysed after stratification for gender, age and participation history. Results Invitation coverage was not impacted in the colorectal and cervical cancer screening program. In the breast cancer screening program invitation coverage went down from 97.5% (2019) to 88.7% (2020), and the backlog of invitations was largely resolved in the first six months of 2021. The willingness to screen was minimally influenced by COVID-19. The breast cancer screening program had a temporary increase in screening interval in the first months following the restart after COVID-19 related shutdown, when it was on average 2.1 months longer than in 2019. Conclusions Willingness to screen was minimally influenced by COVID-19, but there may be an influence on screening coverage because of lower invitation coverage, mainly for the for breast Cancer Screening Program. The increases in screening intervals for the three Cancer Screening Program seem reasonable and would probably not significantly increase the risk of delayed screening cancer diagnoses. When restarting a Cancer Screening Program after a COVID-19 related shutdown, monitoring is crucial.
Druh dokumentu: Article
Other literature type
Popis súboru: application/pdf
Jazyk: English
ISSN: 1471-2407
DOI: 10.1186/s12885-022-09292-y
Prístupová URL adresa: https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-022-09292-y
https://pubmed.ncbi.nlm.nih.gov/35177021
https://doaj.org/article/29c22ab4a2c54b3f83e3bf96bdc490e0
https://hdl.handle.net/1887/3307292
https://repository.uantwerpen.be/docstore/d:irua:11743
https://hdl.handle.net/10067/1873590151162165141
https://biblio.vub.ac.be/vubir/(23e92b6f-de35-49c0-9c7e-068a52cdfed5).html
Rights: CC BY
Prístupové číslo: edsair.doi.dedup.....111b0f9e363a2ffe928a84151917edd4
Databáza: OpenAIRE
Popis
Abstrakt:Background Many breast, colorectal, and cervical cancer screening programs were disrupted due to the COVID-19 pandemic. This study aimed to estimate the short-term impact of the temporary shutdown (from March until May- June) of the cancer screening programs invitations in Flanders (Belgium) by looking at invitation coverage, percentage of people screened after invitation and the screening interval. Methods Yearly invitation coverage was calculated as the number of people who received an invitation, as a proportion of the people who should have received an invitation that year. Weekly response to the invitation was calculated as the number of people who were screened within 40 days of their date of invitation, as a percentage of the people who received an invitation that week (as a proxy for willingness to screen). Weekly screening interval was calculated as the mean number of months between the current screening and the previous screening of all the people who screened that week. The two last indicators were calculated for each week in 2019 and 2020, after which the difference between that week’s value in 2020 and 2019 with 95% confidence intervals. Results of these two indicators were also analysed after stratification for gender, age and participation history. Results Invitation coverage was not impacted in the colorectal and cervical cancer screening program. In the breast cancer screening program invitation coverage went down from 97.5% (2019) to 88.7% (2020), and the backlog of invitations was largely resolved in the first six months of 2021. The willingness to screen was minimally influenced by COVID-19. The breast cancer screening program had a temporary increase in screening interval in the first months following the restart after COVID-19 related shutdown, when it was on average 2.1 months longer than in 2019. Conclusions Willingness to screen was minimally influenced by COVID-19, but there may be an influence on screening coverage because of lower invitation coverage, mainly for the for breast Cancer Screening Program. The increases in screening intervals for the three Cancer Screening Program seem reasonable and would probably not significantly increase the risk of delayed screening cancer diagnoses. When restarting a Cancer Screening Program after a COVID-19 related shutdown, monitoring is crucial.
ISSN:14712407
DOI:10.1186/s12885-022-09292-y